-
1
-
-
0029130866
-
Treatment of opportunist infections in AIDS
-
Sepkowitz L , Armstrong D: Treatment of opportunist infections in AIDS. Lancet 1995;346:588-589.
-
(1995)
Lancet
, vol.346
, pp. 588-589
-
-
Sepkowitz, L.1
Armstrong, D.2
-
2
-
-
0024577325
-
Amphotericin B-incluced changes in renal membrane permeation: A model of nephrotoxicity
-
Schell RE, Tran NV, Bramhall JS: Amphotericin B-incluced changes in renal membrane permeation: A model of nephrotoxicity. Biochem Biophys Res Commun 1989;159: 1165-1170.
-
(1989)
Biochem Biophys Res Commun
, vol.159
, pp. 1165-1170
-
-
Schell, R.E.1
Tran, N.V.2
Bramhall, J.S.3
-
3
-
-
0025274797
-
Amphotericin B nephrotoxicity
-
Sabra R, Branch RA: Amphotericin B nephrotoxicity. Drug Safety 1990; 5:94-108.
-
(1990)
Drug Safety
, vol.5
, pp. 94-108
-
-
Sabra, R.1
Branch, R.A.2
-
4
-
-
0026543169
-
In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release
-
Heyman SN, Clark BA, Kaiser N, Epstein FH, Spokes K Rosen S, Brezis M: In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release. J Antimicrob Chemother 1992;29:69-77.
-
(1992)
J Antimicrob Chemother
, vol.29
, pp. 69-77
-
-
Heyman, S.N.1
Clark, B.A.2
Kaiser, N.3
Epstein, F.H.4
Spokes, K.5
Rosen, S.6
Brezis, M.7
-
5
-
-
0025241257
-
Antifungal and surgical treatment of invasive aspergillosis, review of 2121 published cases
-
Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis, review of 2121 published cases. Rev Infect Dis 1990;12:147-1201.
-
(1990)
Rev Infect Dis
, vol.12
, pp. 147-1201
-
-
Denning, D.W.1
Stevens, D.A.2
-
6
-
-
0344689817
-
Amphotericin B-cholesteryl sulfate complex (ABCD): Stability and tissue distribution of a novel dosage form
-
Mufson D, Guo LSS, Fielding RM: Amphotericin B-cholesteryl sulfate complex (ABCD): Stability and tissue distribution of a novel dosage form. Proc Int Soc Symp Control Rel Bioact Materials 1990;17:81-82.
-
(1990)
Proc Int Soc Symp Control Rel Bioact Materials
, vol.17
, pp. 81-82
-
-
Mufson, D.1
Guo, L.S.S.2
Fielding, R.M.3
-
7
-
-
0025729482
-
Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats
-
Fielding RM, Smith PC, Wang LH, Porter J, Guo LSS: Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob Agents Chemother 1991;35:1208-1213.
-
(1991)
Antimicrob Agents Chemother
, vol.35
, pp. 1208-1213
-
-
Fielding, R.M.1
Smith, P.C.2
Wang, L.H.3
Porter, J.4
Guo, L.S.S.5
-
8
-
-
0024559833
-
Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes
-
Patterson T, Miniter M, Dijkstra J, Szoka F, Ryan J, Andriole V: Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis 1989;159:717-724.
-
(1989)
J Infect Dis
, vol.159
, pp. 717-724
-
-
Patterson, T.1
Miniter, M.2
Dijkstra, J.3
Szoka, F.4
Ryan, J.5
Andriole, V.6
-
9
-
-
0028283641
-
Overview of amphotericin B colloidal dispersion (Amphocil)
-
Stevens DA: Overview of amphotericin B colloidal dispersion (Amphocil). J Infect 1994;28(suppl 1):45-49.
-
(1994)
J Infect
, vol.28
, Issue.SUPPL. 1
, pp. 45-49
-
-
Stevens, D.A.1
-
10
-
-
85047695688
-
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses
-
Oppenheim BA, Herbrecht R, Kusne S: The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 1995;21: 1145-1153.
-
(1995)
Clin Infect Dis
, vol.21
, pp. 1145-1153
-
-
Oppenheim, B.A.1
Herbrecht, R.2
Kusne, S.3
-
11
-
-
0029899107
-
Phase 1 Study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant
-
Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA: Phase 1 Study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 1996;173: 1208-1215.
-
(1996)
J Infect Dis
, vol.173
, pp. 1208-1215
-
-
Bowden, R.A.1
Cays, M.2
Gooley, T.3
Mamelok, R.D.4
Van Burik, J.A.5
-
12
-
-
0344258155
-
Safety and efficacy of amphotericin B colloidal dispersion (ABCD)
-
Abstr 0632
-
Anaissie E, Gurwith M: Safety and efficacy of amphotericin B colloidal dispersion (ABCD). Can J Infect Dis 1995;6(suppl C):286C, Abstr 0632.
-
(1995)
Can J Infect Dis
, vol.6
, Issue.SUPPL. C
-
-
Anaissie, E.1
Gurwith, M.2
-
13
-
-
0028209901
-
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary Aspergillosis
-
Allende MC, Lee JW, Francis P, et al: Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary Aspergillosis. Antimicrob Agents Chemother 1994;38:518-522.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 518-522
-
-
Allende, M.C.1
Lee, J.W.2
Francis, P.3
-
14
-
-
84873778521
-
Nephrotoxicity of amphotericin B, early and late effects in 81 patients
-
Butler WT, Bennett JE, Ailing DW, et al: Nephrotoxicity of amphotericin B, early and late effects in 81 patients. Ann Int Med 1964;61: 175-187.
-
(1964)
Ann Int Med
, vol.61
, pp. 175-187
-
-
Butler, W.T.1
Bennett, J.E.2
Ailing, D.W.3
-
15
-
-
0023634292
-
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis
-
Stamm AM, Diasio RB, Dismukes WE, et al: Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 1987;83:236-242.
-
(1987)
Am J Med
, vol.83
, pp. 236-242
-
-
Stamm, A.M.1
Diasio, R.B.2
Dismukes, W.E.3
-
16
-
-
0025424493
-
Amphotericin revisited: Reassessment of toxicity
-
Clements JS, Peacock JE: Amphotericin revisited: Reassessment of toxicity. Am J Med 1990;88:22N-27N.
-
(1990)
Am J Med
, vol.88
-
-
Clements, J.S.1
Peacock, J.E.2
-
17
-
-
0028919545
-
Pre-treatment regimens for adverse events related to infusion of amphotericin B
-
Goodwin SD, Cleary JD, Walawander CA, Taylor JW, Grasela TH: Pre-treatment regimens for adverse events related to infusion of amphotericin B. Clin Infect Dis 1995;20: 755-761.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 755-761
-
-
Goodwin, S.D.1
Cleary, J.D.2
Walawander, C.A.3
Taylor, J.W.4
Grasela, T.H.5
|